Myriad Genetics, Inc. (MYGN)
4.54
+0.48
(+11.82%)
USD |
NASDAQ |
Oct 02, 16:00
4.54
0.00 (0.00%)
After-Hours: 20:00
Myriad Genetics Gross Profit Margin (Quarterly) : 62.51% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 62.51% |
| March 31, 2026 | 64.72% |
| December 31, 2025 | 66.87% |
| September 30, 2025 | 66.07% |
| June 30, 2025 | 66.82% |
| March 31, 2025 | 68.50% |
| December 31, 2024 | 71.65% |
| September 30, 2024 | 65.31% |
| June 30, 2024 | 64.54% |
| March 31, 2024 | 62.71% |
| December 31, 2023 | 63.17% |
| September 30, 2023 | 64.41% |
| June 30, 2023 | 62.72% |
| March 31, 2023 | 61.42% |
| December 31, 2022 | 63.78% |
| September 30, 2022 | 61.25% |
| June 30, 2022 | 66.59% |
| March 31, 2022 | 64.71% |
| December 31, 2021 | 65.24% |
| September 30, 2021 | 64.49% |
| June 30, 2021 | 64.52% |
| March 31, 2021 | 61.99% |
| June 30, 2020 | 44.31% |
| March 31, 2020 | 60.12% |
| December 31, 2019 | 66.79% |
| Date | Value |
|---|---|
| September 30, 2019 | 65.11% |
| June 30, 2019 | 69.41% |
| March 31, 2019 | 70.54% |
| December 31, 2018 | 68.87% |
| September 30, 2018 | 68.81% |
| June 30, 2018 | 71.63% |
| March 31, 2018 | 70.84% |
| December 31, 2017 | 71.42% |
| September 30, 2017 | 70.75% |
| June 30, 2017 | 78.80% |
| March 31, 2017 | 77.50% |
| December 31, 2016 | 77.40% |
| September 30, 2016 | 77.46% |
| June 30, 2016 | 78.55% |
| March 31, 2016 | 78.90% |
| December 31, 2015 | 79.00% |
| September 30, 2015 | 80.11% |
| June 30, 2015 | 80.25% |
| March 31, 2015 | 79.84% |
| December 31, 2014 | 79.47% |
| September 30, 2014 | 77.51% |
| June 30, 2014 | 83.59% |
| March 31, 2014 | 85.45% |
| December 31, 2013 | 87.19% |
| September 30, 2013 | 87.16% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Natera, Inc. | 63.70% |
| Sera Prognostics, Inc. | -606.7% |
| BioRestorative Therapies, Inc. | -157.8% |
| CareDx, Inc. | 73.37% |
| Exagen, Inc. | 61.27% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -31.80% |
| Return on Assets | -16.44% |
| Return on Invested Capital | -20.33% |
| Profit Margin (Quarterly) | -22.65% |
| Operating Margin (Quarterly) | -20.40% |
| Return on Net Operating Assets | -21.42% |